. "2 Phthalate Exposure Assessment in Humans." Phthalates and Cumulative Risk Assessment The Task Ahead. Washington, DC: The National Academies Press, 2008.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Phthalates and Cumulative Risk Assessment: The Tasks Ahead
Sorensen, L.K. 2006. Determination of phthalates in milk and milk products by liquid chromatography/tandem mass spectrometry. Rapid. Commun. Mass Spectrom 20(7): 1135-1143.
Weuve, J., B.N. Sanchez, A.M. Calafat, T. Schettler, R.A.Green, H. Hu, and R. Hauser. 2006. Exposure to phthalates in neonatal intensive care unit infants: Urinary concentrations of monoesters and oxidative metabolites. Environ. Health Perspect. 114(9):1424-1431.
Wittassek, M., and J. Angerer. 2008. Phthalates: Metabolism and exposure. Int. J. Androl. 31(2):131-138.
Wittassek, M., G.A. Wiesmuller, H.M. Koch, R. Eckard, L. Dobler, J. Muller, J. Angerer, and C. Schluter. 2007. Internal phthalate exposure over the last two decades—a retrospective human biomonitoring study. Int. J. Hyg. Environ. Health 210(3-4):319-333.
Wolff, M.S., S.M. Engel, G.S. Berkowitz, X. Ye, M.J. Silva, C. Zhu, J. Wetmur, and A.M. Calafat. 2008. Prenatal phenol and phthalate exposures and birth outcomes. Environ. Health Perspect. 116(8):1092-1097.